USP comments to FDA on the Inactive Ingredient Database (IID) and Maximum Daily Exposure (MDE) Information (2022)

USP comments to FDA on Docket No. FDA-2022-N-0236 for “Prioritizing the Addition of Maximum Daily Exposure Information and Removing Dosage Form Information from the Inactive Ingredient Database. Comments were submitted in 2022.